Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

TXG holding history

10x Genomics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXG overviewAll 13F holders of TXGFull Q2 2026 holdings

Shares (Q2 2026)
2,604
Value
$99.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TXG by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,604$99.8K<0.1%+43+1.7%AddedHolders
Q1 20262,561$54.4K<0.1%00.0%UnchangedHolders
Q4 20252,561$41.8K<0.1%+55+2.2%AddedHolders
Q3 20252,506$29.3K<0.1%00.0%UnchangedHolders
Q2 20252,506$29.0K<0.1%−15,082−85.8%ReducedHolders
Q1 202517,588$153.5K<0.1%+2,686+18.0%AddedHolders
Q4 202414,902$214.0K<0.1%−2,321−13.5%ReducedHolders
Q3 202417,223$388.9K<0.1%+1,118+6.9%AddedHolders
Q2 202416,105$313.2K<0.1%−489−2.9%ReducedHolders
Q1 202416,594$622.8K<0.1%−70.0%ReducedHolders
Q4 202316,601$929.0K<0.1%−773−4.4%ReducedHolders
Q3 202317,374$716.7K<0.1%+40.0%AddedHolders
Q2 202317,370$969.9K<0.1%−9−0.1%ReducedHolders
Q1 202317,379$969.6K<0.1%−3,010−14.8%ReducedHolders
Q4 202220,389$743.0K<0.1%+154+0.8%AddedHolders
Q3 202220,235$576.0K<0.1%+69+0.3%AddedHolders
Q2 202220,166$913.0K<0.1%−68−0.3%ReducedHolders
Q1 202220,234$1.51M0.1%+12,810+172.5%AddedHolders
Q4 20217,424$1.11M<0.1%+7,414+74,140.0%AddedHolders
Q3 202110$1.00K<0.1%−1−9.1%ReducedHolders
Q2 202111$2.00K<0.1%−3,469−99.7%ReducedHolders
Q1 20213,480$630.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.